Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations

Vaccine

Volumn 35, Issue 43, 2017, Pages 5753-5755

 

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cervical cancer; HPV; Human papillomavirus; Licensurenonavalent(9 valent) vaccine; Vaccination strategies; WHO position paper; World Health Organization

Indexed keywords

DIPHTHERIA TETANUS VACCINE; WART VIRUS VACCINE;

CANCER PREVENTION; DRUG EFFICACY; HUMAN; IMMUNIZATION; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPEATED DRUG DOSE; UTERINE CERVIX CANCER; VACCINATION; WORLD HEALTH ORGANIZATION; HEALTH CARE POLICY; IMMUNOLOGY; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; STANDARDS;

HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PUBLIC HEALTH; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 85020208951     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.05.069     Document Type: Note

References (9)

1. Human papillomavirus vaccines: WHO position paper, October 2014, Weekly Epidemiological Record No. 43 (2014) 465–492.
2. Human papillomavirus vaccines: WHO position paper, May 2017, Weekly Epidemiological Record No. 19 92 (2017) 241–268.
3. Background Documents and Presentations Presented During the SAGE Meeting, October 2016 < http://www.who.int/immunization/sage/meetings/2016/october/presentations_background_docs/en/> (accessed May 2017).
4. Guide to Introducing HPV Vaccine into National Immunization Programmes, World Health Organization, Geneva, 2017 < http://www.apps.who.int/iris/bitstream/10665/253123/1/9789241549769-eng.pdf?ua=1> (accessed May 2017).
5. Evidence to Recommendation Table, Assessment of Gender-Based Immunization < http://www.who.int/entity/immunization/policy/position_papers/hpv_gender_recommendation_table.pdf> (accessed May 2017).
6. Evidence to Recommendation Table. Vaccination of Multiple Female Age-Cohorts < http://www.who.int/entity/immunization/policy/position_papers/hpv_female_age_cohorts_recommendation_table.pdf> (accessed May 2017).
7. Evidence to Recommendation Table on Choice of Vaccine < http://www.who.int/entity/immunization/policy/position_papers/hpv_choice_recommendation_table.pdf> (accessed May 2017).
8. Monitoring the Coverage and Impact of Human Papillomavirus Vaccine - Report of WHO Meeting, November 2009, Weekly Epidemiological Record No. 25 (2010) 237–243.
9. International Agency for Research on Cancer, Planning and Developing Population-Based Cancer Registration in Low- and Middle-Income Settings < http://www.iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub43/index.php> (accessed May 2017).